Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03384563
PHASE4

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

Sponsor: Baylor College of Medicine

View on ClinicalTrials.gov

Summary

The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.

Key Details

Gender

All

Age Range

1 Month - 36 Months

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2018-02-18

Completion Date

2025-12-31

Last Updated

2025-09-22

Healthy Volunteers

Yes

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 9 arms

Locations (1)

Texas Children's Hospital

Houston, Texas, United States